VRTX PEG: current value, 10-year range and year-by-year history
Cash & Leverage
VRTX's peg is right around its 10-year median of 1.3.
PEG History
VRTX PEG by year
Yearly range of VRTX’s peg from 2017 to 2026. Over the full period it ranged from 0.3 to 30.8, averaging 3.5.
| Year | Low | Average | High | Year-end |
|---|---|---|---|---|
| 2026 | 1.5 | 2.7 | 3.9 | 1.7 |
| 2025 | 2.2 | 3.5 | 4.8 | 3.6 |
| 2024 | 1.9 | 2.4 | 2.8 | 2.3 |
| 2023 | 0.3 | 0.5 | 0.8 | 0.8 |
| 2022 | 0.3 | 0.4 | 0.4 | 0.3 |
| 2017 | 1.5 | 28.9 | 30.8 | 29.7 |
Get notified when VRTX PEG crosses a threshold
Free — one alert setup, notifications by push, Telegram, or Discord.
P/E ratio divided by the earnings growth rate. Peter Lynch's tool for checking whether a higher P/E is actually justified by faster growth. PEG ≤ 1.0 is Lynch's "fairly priced" threshold.
P/E Ratio / Annual EPS Growth Rate (%)A low PEG vs the stock's own history suggests the market may not be fully pricing in the growth rate — the combination of P/E and growth looks unusually attractive.
- Only meaningful for businesses with real, consistent earnings growth. Irrelevant for cyclicals, early-stage companies, and income stocks.
- Forward PEG is based on analyst estimates that are frequently optimistic — treat it as a sanity check, not a primary signal.
Is VRTX PEG High or Low Right Now?
Vertex Pharmaceuticals Incorporated's PEG is currently 1.7, which is around average relative to its 10-year historical range. The 10-year median PEG for VRTX is approximately 1.3. See all VRTX valuation metrics →
Unlock 10y, 15y, 20y, and 30y history with peer comparison and CSV export.